Drawing for ISARNA THERAPEUTICS

USPTO serial 79149209

ISARNA THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 4701958Status 404
Filing date
Status date
Registration date
Mar 17, 2015
Examiner
CROWLEY, SEAN MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ISARNA THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia W. Stangle

Claudia W. Stangle Leydig, Voit & Mayer, Ltd.Two Prudential Plaza, 180 N. Stetson AveSuite 4900Chicago, IL 60601

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals; sanitary preparations for medical purposes, liquids, solutions or active agents for use in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animalsSECTION 71 - CANCELLED
042Scientific and technological services, namely, research and design relating thereto in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals; industrial analysis in the nature of testing pharmaceuticals to ensure compliance with industry standards; providing scientific research services in the fields of medicine, namely, research on tumor treatment, pain, neurological diseases and similar malfunctioning of the human body or of animals; design and development of computer hardware and software in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animalsSECTION 71 - CANCELLED
044Medical services in the pharmaceutical field, namely, the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body; veterinary services in the field of the treatment of tumors, pain, neurological diseases and similar malfunctioning of animals; hygienic and beauty care for human beings or animals, using liquids, solutions or active agents in the cosmetic field, namely, the plastic surgery and anaplastic field or anti-aging treatmentSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 8, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sep 8, 2024DETHDEATH OF INTERNATIONAL REGISTRATION
Oct 16, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB
Sep 16, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 15, 2022INPCINVALIDATION PROCESSED
Jul 26, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 26, 2021C71TCANCELLED SECTION 71
Mar 17, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 23, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 15, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 27, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2015FIMPFINAL DISPOSITION PROCESSED
Jun 17, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 30, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 30, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 27, 2014GPNXNOTIFICATION PROCESSED BY IB
Dec 10, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 10, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 10, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 25, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 20, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2014ALIEASSIGNED TO LIE
Nov 11, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2014RFNTREFUSAL PROCESSED BY IB
Aug 2, 2014MAFRAPPLICATION FILING RECEIPT MAILED
Aug 1, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 1, 2014RFRRREFUSAL PROCESSED BY MPU
Aug 1, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 31, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2014DOCKASSIGNED TO EXAMINER
Jul 29, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 21, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance